Participant flow

Panobinostat/Bortezomib/Dexamethasone in Relapsed or Relapsed-and-refractory Multiple Myeloma · Source last updated 2024-07-12

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

groups

1. description

   Participants received 20 milligrams (mg) panobinostat thrice a week (TIW), 2 weeks on/1 week off in combination with subcutaneous bortezomib and oral dexamethasone.

   id

   FG000

   title

   Arm A - Panobinostat (20 mg, TIW)

2. description

   Participants received 20 mg panobinostat twice a week (BIW), 2 weeks on/1 week off in combination with subcutaneous bortezomib and oral dexamethasone.

   id

   FG001

   title

   Arm B - Panobinostat (20 mg, BIW)

3. description

   Participants received 10 mg panobinostat TIW, 2 weeks on/1 week off in combination with subcutaneous bortezomib and oral dexamethasone.

   id

   FG002

   title

   Arm C - Panobinostat (10 mg, TIW)

periods

1. milestones

   1. achievements

      1. group Id

         FG000

         num Subjects

         82

      2. group Id

         FG001

         num Subjects

         83

      3. group Id

         FG002

         num Subjects

         83

      comment

      Full analysis set (FAS): all participants to whom study treatment was assigned by randomization.

      type

      STARTED

   2. achievements

      1. group Id

         FG000

         num Subjects

         79

      2. group Id

         FG001

         num Subjects

         82

      3. group Id

         FG002

         num Subjects

         80

      comment

      Safety Set: all participants who received any study treatment.

      type

      Received at Least 1 Dose of Study Drug

   3. achievements

      1. group Id

         FG000

         num Subjects

         82

      2. group Id

         FG001

         num Subjects

         83

      3. group Id

         FG002

         num Subjects

         83

      type

      COMPLETED

   4. achievements

      1. group Id

         FG000

         num Subjects

         0

      2. group Id

         FG001

         num Subjects

         0

      3. group Id

         FG002

         num Subjects

         0

      type

      NOT COMPLETED

   title

   Overall Study

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice